Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis

Ticker
SPRY

Price
10.57
Stock movement up
+0.42 (4.40%)
Company name
ARS Pharmaceuticals, Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
985.30M
Ent value
1.05B
Price/Sales
388.22
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return (CAGR)
-27.33%
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Last updated: 2025-12-04

DIVIDENDS

SPRY does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales388.22
Price to Book-
EV to Sales415.65

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count98.83M
EPS (TTM)-0.81
FCF per share (TTM)-0.87

Income statement

Loading...
Income statement data
Revenue (TTM)142.77M
Gross profit (TTM)121.66M
Operating income (TTM)-90.79M
Net income (TTM)-80.04M
EPS (TTM)-0.81
EPS (1y forward)-1.35

Margins

Loading...
Margins data
Gross margin (TTM)85.21%
Operating margin (TTM)-63.59%
Profit margin (TTM)-56.06%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash59.56M
Net receivables36.45M
Total current assets338.86M
Goodwill0.00
Intangible assets14.73M
Property, plant and equipment2.65M
Total assets372.80M
Accounts payable8.38M
Short/Current long term debt1.53M
Total current liabilities50.88M
Total liabilities225.15M
Shareholder's equity147.66M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-85.38M
Capital expenditures (TTM)641.00K
Free cash flow (TTM)-86.02M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-54.21%
Return on Assets-21.47%
Return on Invested Capital-32.74%
Cash Return on Invested Capital-35.19%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open9.50
Daily high10.02
Daily low9.44
Daily Volume1.43M
All-time high60.41
1y analyst estimate28.83
Beta0.80
EPS (TTM)-0.81
Dividend per share0.00
Ex-div date-
Next earnings date19 Mar 2026

Downside potential

Loading...
Downside potential data
SPRYS&P500
Current price drop from All-time high-82.50%-0.89%
Highest price drop-88.86%-19.00%
Date of highest drop20 Nov 20258 Apr 2025
Avg drop from high-78.45%-2.49%
Avg time to new high-6 days
Max time to new high290 days89 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
SPRY (ARS Pharmaceuticals, Inc) company logo
Marketcap
985.30M
Marketcap category
Small-cap
Description
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions. The company is involved in the development of neffy, a needle-free and low-dose intranasal epinephrine nasal spray for rescue medication for people with Type I severe allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. The company was founded in 2015 and is headquartered in San Diego, California.
Employees
162
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...